Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Citrocil
2. Dihydrostreptomycin
3. Dihydrostreptomycin Sulfate
4. Sulfate, Dihydrostreptomycin
1. Streptomycin, Dihydro-, Sulfate
2. Dihydrostreptomycin Sulfate
3. 1425-61-2
4. Einecs 215-843-1
5. Schembl192910
6. Nsc 756739
7. D-streptamine, O-2-deoxy-2-(methylamino)-alpha-l-glucopyranosyl-(1-2)-o-5-deoxy-3-c-(hydroxymethyl)-alpha-l-lyxofuranosyl-(1-4)-n,n'-bis(aminoiminomethyl)-, Sulfate (salt)
Molecular Weight | 681.7 g/mol |
---|---|
Molecular Formula | C21H43N7O16S |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 9 |
Exact Mass | 681.24869948 g/mol |
Monoisotopic Mass | 681.24869948 g/mol |
Topological Polar Surface Area | 423 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 993 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 15 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Market Place
ABOUT THIS PAGE
A Dihydrostreptomycin Sulphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydrostreptomycin Sulphate, including repackagers and relabelers. The FDA regulates Dihydrostreptomycin Sulphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydrostreptomycin Sulphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydrostreptomycin Sulphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydrostreptomycin Sulphate supplier is an individual or a company that provides Dihydrostreptomycin Sulphate active pharmaceutical ingredient (API) or Dihydrostreptomycin Sulphate finished formulations upon request. The Dihydrostreptomycin Sulphate suppliers may include Dihydrostreptomycin Sulphate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydrostreptomycin Sulphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydrostreptomycin Sulphate CEP of the European Pharmacopoeia monograph is often referred to as a Dihydrostreptomycin Sulphate Certificate of Suitability (COS). The purpose of a Dihydrostreptomycin Sulphate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dihydrostreptomycin Sulphate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dihydrostreptomycin Sulphate to their clients by showing that a Dihydrostreptomycin Sulphate CEP has been issued for it. The manufacturer submits a Dihydrostreptomycin Sulphate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dihydrostreptomycin Sulphate CEP holder for the record. Additionally, the data presented in the Dihydrostreptomycin Sulphate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dihydrostreptomycin Sulphate DMF.
A Dihydrostreptomycin Sulphate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dihydrostreptomycin Sulphate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dihydrostreptomycin Sulphate suppliers with CEP (COS) on PharmaCompass.
Dihydrostreptomycin Sulphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydrostreptomycin Sulphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydrostreptomycin Sulphate GMP manufacturer or Dihydrostreptomycin Sulphate GMP API supplier for your needs.
A Dihydrostreptomycin Sulphate CoA (Certificate of Analysis) is a formal document that attests to Dihydrostreptomycin Sulphate's compliance with Dihydrostreptomycin Sulphate specifications and serves as a tool for batch-level quality control.
Dihydrostreptomycin Sulphate CoA mostly includes findings from lab analyses of a specific batch. For each Dihydrostreptomycin Sulphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydrostreptomycin Sulphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydrostreptomycin Sulphate EP), Dihydrostreptomycin Sulphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydrostreptomycin Sulphate USP).
LOOKING FOR A SUPPLIER?